HRTX vs NVR · rev $72.4M vs P/E 15, rev $4.21B
Heron Therapeuti (HRTX) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Heron Therapeuti (HRTX) is a biotechnology company listed on US.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported HRTX revenue for 2026-06-30 was $72.4M. Net income was -$13.6M. HRTX currently screens at market cap $332.6M.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
HRTX currently screens at market cap $332.6M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the HRTX and NVR stock pages for the full models.
Not investment advice.